FOXO TECHNOLOGIES INC. (FOXO) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $11.64M; Senior NotesUSD (m); Notes PayableUSD (m).
- 2026-03-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $3.21M; Senior NotesUSD (m); Notes PayableUSD (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $2.15M; Senior NotesUSD (m); Notes PayableUSD (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD (m); Senior NotesUSD $255.01K; Notes PayableUSD (m).
FOXO TECHNOLOGIES INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Notes Payable, Current USD | Senior Notes USD | Notes Payable USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Unamortized Discount USD | Convertible Notes Payable USD | Long-term Debt USD | Debt Instrument, Collateral Amount USD | Debt Instrument, Annual Principal Payment USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.64M | (m) | (m) | (m) | 20.00% | (m) | $59.33K | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $3.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.15M | (m) | (m) | $400.00K | (m) | (m) | $59.33K | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $255.01K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $2.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $100.00K | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $2.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-15 | (m) | (m) | (m) | (m) | $47.50K | (m) | (m) | $5.00K | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.50M | $7.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $10.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-09 | (m) | (m) | (m) | $650.00K | (m) | (m) | 50.01% | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $9.56M | (m) | $31.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $7.98M | (m) | $7.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $386.00K | (m) | (m) | (m) | (m) | (m) | $196.00K | (m) | (m) | (m) | (m) | $256.00K |
| 2023-12-31 | (m) | (m) | (m) | $4.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $256.00K |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $256.00K |
| 2023-09-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $247.00K | (m) | (m) |
| 2023-06-30 | (m) | $3.86M | (m) | (m) | (m) | 15.00% | (m) | (m) | (m) | (m) | (m) | (m) | $256.00K |
| 2023-03-31 | (m) | $3.37M | (m) | (m) | (m) | 15.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $1.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $1.41M | (m) | 15.00% | (m) | (m) | $88.38M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | 15.00% | (m) | (m) | $88.38M | $2.92M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $560.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $200.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $300.00K | (m) |
| 2022-02-23 | (m) | (m) | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |